pharma – Page 2 – Instametta

Pharma Giant Eli Lilly Is Paying $2.75 Billion for AI-Designed Drugs

Eli Lilly is betting big that generative AI can do more than just write code and create images. It can…

Thomas Rowland, an executive at ANI Pharmaceuticals (NASDAQ:ANIP), reported the sale of 4,772 shares of common stock in an open-market…

Novartis (NYSE: NVS) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas…

Kelvn | Istock | Getty Images Shares of Japanese drugmaker Sumitomo Pharma fell over 12% Friday on what appeared to…

Sumitomo Pharma Co. shares declined after a Japanese government panel endorsed a conditional approval for its regenerative therapy, built on…

Asad Haider, head of the U.S. Healthcare Business Unit at Goldman Sachs Research, says 2026 is a pivotal year for…

Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the price…

Last Updated: Jan. 26, 2026 at 9:25 p.m. ETFirst Published: Jan. 26, 2026 at 8:55 p.m. ET South Korean automaker and pharmaceutical…

U.S. President Donald Trump speaks at the 2025 Asia-Pacific Economic Cooperation (APEC) CEO Summit in Gyeongju, South Korea, October 29,…

Entropy founder Tux Pacific says the startup is winding up and will return capital to investors. Entropy founder and CEO…